Targeting CBP/p300 Overcomes Acquired Vincristine Resistance in Medulloblastoma
Göktuğ Karabiyik, Ozlem Yedier-Bayram, Feridun Aksu, Tolga Lokumcu, Ali Cenk Aksu, Fidan Seker-Polat, Ezgi Ozyerli‐Goknar, Adam P. Cribbs, Udo C. T. Oppermann, Tugba Bagci Onder
This study identifies CBP/p300 inhibition as a strategy to overcome vincristine resistance in medulloblastoma by targeting genes involved in drug resistance.
bioRxiv · Jul 28, 2026 · PreprintCancer Biology